An alternative analysis of illicit opioid use during treatment in a randomized trial of extended-release naltrexone versus buprenorphine-naloxone: A per-protocol and completers analysis

BACKGROUND: The distinct pharmacological properties and clinical uses of extended-release naltrexone (XR-NTX) and sublingual buprenorphine-naloxone (BUP-NX) present challenges in analyzing patient outcomes. METHODS: We conducted a secondary analysis of a multi-site randomized trial comparing XR-NTX...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Drug Alcohol Depend
Autori principali: Mitchell, Mary M., Schwartz, Robert P., Choo, Tse-Hwei, Pavlicova, Martina, O’Grady, Kevin E., Gryczynski, Jan, Stitzer, Maxine L., Nunes, Edward V., Rotrosen, John
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2020
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8034542/
https://ncbi.nlm.nih.gov/pubmed/33352487
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.drugalcdep.2020.108422
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi